Commerce Bank’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,853
| Closed | -$892K | – | 1206 |
|
|
2021
Q2 | $892K | Buy |
4,853
+20
| +0.4% | +$3.43K | 0.01% | 648 |
|
|
2021
Q1 | $739K | Buy |
4,833
+14
| +0.3% | +$2.17K | 0.01% | 687 |
|
|
2020
Q4 | $753K | Sell |
4,819
-545
| -10% | -$70K | 0.01% | 647 |
|
|
2020
Q3 | $613K | Sell |
5,364
-286
| -5% | -$30.9K | 0.01% | 633 |
|
|
2020
Q2 | $634K | Buy |
5,650
+1,439
| +34% | +$153K | 0.01% | 599 |
|
|
2020
Q1 | $378K | Buy |
4,211
+706
| +20% | +$69.3K | ﹤0.01% | 681 |
|
|
2019
Q4 | $379K | Buy |
3,505
+21
| +0.6% | +$2.25K | ﹤0.01% | 741 |
|
|
2019
Q3 | $341K | Buy |
3,484
+117
| +3% | +$13.2K | ﹤0.01% | 736 |
|
|
2019
Q2 | $441K | Buy |
3,367
+746
| +28% | +$96.1K | ﹤0.01% | 643 |
|
|
2019
Q1 | $355K | Sell |
2,621
-927
| -26% | -$115K | ﹤0.01% | 669 |
|
|
2018
Q4 | $345K | Buy |
3,548
+1,248
| +54% | +$148K | ﹤0.01% | 646 |
|
|
2018
Q3 | $320K | Buy |
2,300
+548
| +31% | +$68.7K | ﹤0.01% | 718 |
|
|
2018
Q2 | $218K | Buy |
+1,752
| New | +$205K | ﹤0.01% | 815 |
|
|
2016
Q1 | – | Sell |
-1,169
| Closed | -$223K | – | 814 |
|
|
2015
Q4 | $223K | Sell |
1,169
-260
| -18% | -$45.4K | ﹤0.01% | 731 |
|
|
2015
Q3 | $223K | Buy |
+1,429
| New | +$261K | ﹤0.01% | 732 |
|
|
2013
Q3 | – | Sell |
-2,452
| Closed | -$226K | – | 787 |
|
|
2013
Q2 | $226K | Buy |
+2,452
| New | +$236K | ﹤0.01% | 686 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM